Logo do repositório
 
Publicação

HTA reshaping

dc.contributor.authorPereira, João
dc.contributor.authorAlves, Joana
dc.contributor.authorRodrigues, Bernardo
dc.contributor.authorCaetano, Ricardo
dc.contributor.authorBrito-Cruz, Pedro
dc.contributor.authorSousa, Joana
dc.contributor.authorBarata, Branca
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.institutionComprehensive Health Research Centre (CHRC) - Pólo ENSP
dc.contributor.institutionCentro de Investigação em Saúde Pública (CISP/PHRC)
dc.contributor.pblKarger
dc.date.accessioned2021-07-12T22:17:50Z
dc.date.available2021-07-12T22:17:50Z
dc.date.issued2021
dc.descriptionFunding Information: MEA and MIP. These methods might be a relevant mechanism to improve access. However, they should be supported by an improved registry database. Participants identified the possibility of these databases being (partially) funded by the pharmaceutical industry. MIP implementation must be assured by accurate prescription tracking. Publisher Copyright: © 2021 The Author(s). Published by S. Karger AG, Basel on behalf of NOVA National School of Public Health.
dc.description.abstractIntroduction: Health technology assessment (HTA) aims to provide decision makers with relevant data to make informed choices. Recent changes in the Portuguese HTA framework have altered substantially the assessment methodology with regard to economic evaluation, with potential impacts on access and process efficiency. The HTA Reshaping Project had as its main objective informing the debate on HTA in Portugal, thereby identifying improvement opportunities and solutions to the HTA framework that address future challenges. Methods: The project comprised several phases, i.e., (1) mapping and evaluation of different HTA frameworks across Europe, identifying best practices and key variables to consider in future frameworks; (2) conduction of in-depth interviews with relevant stakeholders (n = 11); and (3) development of 2 workshops - one with young professionals (n = 12) and another with relevant HTA stakeholders (n = 19) - to consolidate and further explore vital elements of HTA, aimed at brainstorming ideas and developing solutions to improve some of the most critical points, with a view to addressing future challenges. Results: The comparison of HTA frameworks showed that their purpose and sophistication vary across European countries. For example, the need for economic evidence is not unanimous, and reimbursement agreements vary considerably. Among the stakeholders interviewed there was a high level of agreement on priorities that should be addressed, e.g., expanding and creating national level registries and assuring patient participation throughout the HTA process. The possibility of using managed entry agreements to enhance patients' access, applying multi-indication pricing for medicines with different therapeutic values per indication, and improvement of registry/system interoperability gathered a moderate level of agreement. Conclusions: The Portuguese HTA framework might be further adapted to upcoming challenges and should evolve to improve access to innovative therapies. There is still a long path towards the convergence of HTA frameworks in EU member states.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent195137
dc.identifier.doi10.1159/000516501
dc.identifier.issn2504-3145
dc.identifier.otherPURE: 32121589
dc.identifier.otherPURE UUID: b8c909c9-da2b-4d7a-861b-3b2a0c45c9dc
dc.identifier.otherScopus: 85109187031
dc.identifier.urihttp://hdl.handle.net/10362/120913
dc.language.isomul
dc.peerreviewedyes
dc.subjectEconomic evaluation
dc.subjectHealth financing
dc.subjectHealth technology assessment
dc.subjectInnovative medicines
dc.subjectMarket access
dc.subjectHealth Policy
dc.subjectPublic Health, Environmental and Occupational Health
dc.subjectSDG 3 - Good Health and Well-being
dc.titleHTA reshaping
dc.title.alternativeReformulação da ATSrepensando o quadro da avaliação de tecnologias da saúde em Portugalen
dc.title.subtitlerethinking the health technology assessment framework in Portugal
dc.typejournal article
degois.publication.firstPage
degois.publication.issue1
degois.publication.lastPage
degois.publication.titlePortuguese Journal of Public Health
degois.publication.volume39
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Pereira_PJPH_2021_39_36.pdf
Tamanho:
190.56 KB
Formato:
Adobe Portable Document Format